These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28867738)

  • 1. Characterization of β-Estradiol 3-Glucuronidation in Rat Brain.
    Asai Y; Sakakibara Y; Onouchi H; Nadai M; Katoh M
    Biol Pharm Bull; 2017; 40(9):1556-1560. PubMed ID: 28867738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species and Tissue Differences in β-Estradiol 17-Glucuronidation.
    Asai Y; Sakakibara Y; Kondo M; Nadai M; Katoh M
    Biol Pharm Bull; 2017; 40(10):1754-1758. PubMed ID: 28966247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
    Tachibana M; Tanaka M; Masubuchi Y; Horie T
    Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.
    Mano Y; Usui T; Kamimura H
    Pharm Res; 2006 Jul; 23(7):1502-8. PubMed ID: 16783480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.
    Williams JA; Ring BJ; Cantrell VE; Campanale K; Jones DR; Hall SD; Wrighton SA
    Drug Metab Dispos; 2002 Nov; 30(11):1266-73. PubMed ID: 12386134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of β-Naphthoflavone on Ugt1a6 and Ugt1a7 Expression in Rat Brain.
    Sakakibara Y; Katoh M; Kondo Y; Nadai M
    Biol Pharm Bull; 2016; 39(1):78-83. PubMed ID: 26725430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of UGT1A subfamily in rat brain.
    Sakakibara Y; Katoh M; Imai K; Kondo Y; Asai Y; Ikushiro S; Nadai M
    Biopharm Drug Dispos; 2016 Jul; 37(5):314-9. PubMed ID: 27061716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
    Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
    Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
    Wen Z; Tallman MN; Ali SY; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of bilirubin and its glucuronides in liver microsomes and recombinant UGT1A1 enzyme incubation systems by HPLC method and its application to bilirubin glucuronidation studies.
    Ma G; Lin J; Cai W; Tan B; Xiang X; Zhang Y; Zhang P
    J Pharm Biomed Anal; 2014 Apr; 92():149-59. PubMed ID: 24525562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
    Malfatti MA; Felton JS
    Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Chloro-5-[4-(1-Hydroxycyclobutyl)Phenyl]-1
    Lapham K; Lin J; Novak J; Orozco C; Niosi M; Di L; Goosen TC; Ryu S; Riccardi K; Eng H; Cameron KO; Kalgutkar AS
    Drug Metab Dispos; 2018 Dec; 46(12):1836-1846. PubMed ID: 30194276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
    Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Phenobarbital on Expression of UDP-Glucuronosyltransferase 1a6 and 1a7 in Rat Brain.
    Sakakibara Y; Katoh M; Kondo Y; Nadai M
    Drug Metab Dispos; 2016 Mar; 44(3):370-7. PubMed ID: 26684499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Single-Walled Carbon Nanotubes on UDP-Glucuronosyltransferase 1A Activity in Human Liver.
    Asai Y; Nadai M; Katoh M
    Biol Pharm Bull; 2022; 45(4):446-451. PubMed ID: 35370268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucuronidation of thyroxine in human liver, jejunum, and kidney microsomes.
    Yamanaka H; Nakajima M; Katoh M; Yokoi T
    Drug Metab Dispos; 2007 Sep; 35(9):1642-8. PubMed ID: 17591679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the function of the UDP-glucuronosyltransferase 1A subfamily by cytochrome P450 3A4: different susceptibility for UGT isoforms and UGT1A1/7 variants.
    Ishii Y; Koba H; Kinoshita K; Oizaki T; Iwamoto Y; Takeda S; Miyauchi Y; Nishimura Y; Egoshi N; Taura F; Morimoto S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
    Drug Metab Dispos; 2014 Feb; 42(2):229-38. PubMed ID: 24255116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.